Back
Allogene Therapeutics Stock Predictions
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
26
ALLO
Allogene Therapeutics
Last Price:
2.96
Seasonality Move:
10.59%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!Allogene Therapeutics Stock Forecast
-
Is Allogene Therapeutics Stock Undervalued?
The current Allogene Therapeutics [ALLO] share price is $2.97. The Score for ALLO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal. - ALLO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Allogene Therapeutics Stock Go Up Next Year?
Data Unavailable
Allogene Therapeutics Stock Rating
Data Unavailable
Allogene Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
allogene.com
52-Week Data
52-Week High:
6.89
52-Week Low:
2.23
Prediction Charts
Market Cap:
502.2M
Price in USD:
2.97
Volume:
1.4M
Beta:
0.95
Technical Analysis
SMA50:
4.18
SMA100:
3.82
SMA200:
3.68
52-Wk Change:
-44.49%
Stock Predictions
-
Is Allogene Therapeutics stock public?
Yes, Allogene Therapeutics is a publicly traded company. -
What is the Allogene Therapeutics stock quote today?
The Allogene Therapeutics stock price is 2.97 USD today. -
How to buy Allogene Therapeutics stock online?
You can buy Allogene Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-15 | 3.86 | 3.55 | 3.88 | 3.54 |
| Apr-16 | 3.50 | 3.50 | 3.56 | 3.40 |
| Apr-17 | 3.57 | 3.52 | 3.58 | 3.46 |
| Apr-18 | 3.52 | 3.45 | 3.56 | 3.45 |
| Apr-19 | 3.45 | 3.47 | 3.56 | 3.38 |
| Apr-22 | 3.49 | 3.40 | 3.63 | 3.38 |
| Apr-23 | 3.41 | 3.37 | 3.53 | 3.36 |
| Apr-24 | 3.37 | 3.04 | 3.42 | 3.03 |
| Apr-25 | 2.99 | 2.86 | 2.99 | 2.84 |
| Apr-26 | 2.87 | 2.89 | 2.93 | 2.75 |
| Apr-29 | 2.94 | 2.84 | 3.10 | 2.79 |
| Apr-30 | 2.80 | 2.76 | 2.91 | 2.70 |
| May-1 | 2.78 | 2.92 | 3.03 | 2.74 |
| May-2 | 3.07 | 2.97 | 3.09 | 2.92 |
Allogene Therapeutics Earnings
Data Unavailable
Allogene Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.39 per share, and a decrease next year of $0.04 per share.
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.